Informations bibliographiques
Ligne directriceWHO consolidated guidelines for the management of common childhood illness: management of asthma in children and adolescents and bronchiolitis in infants and young children
Année de publication2026
Institution émettriceWorld Health Organization
Recommandation
Mise à jour
Intravenous (IV) magnesium sulfate should be the preferred option for second-line therapy and IV short-acting beta2 agonist (SABA) the preferred option for third-line therapy in severe paediatric asthma exacerbations not responding to standard first-line therapy.
Recommandé en faveur
Conditionnelle
Certitude des données probantes
Très faible